Furthermore, NF-κB activates genes linked to cardiovascular diseases, such as cardiac remodeling and heart failure, as well as metabolic disorders like type 2 diabetes mellitus and obesity—conditions that often complicate PsA and RA [45, 46]. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.